S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Enlivex Therapeutics Ltd (ENLV)
Enlivex Therapeutics Ltd (ENLV) Financials

ENLV Enlivex Therapeutics Ltd

1.61

-0.06 (-3.59%)

Pre Market

Last Updated: 22:53:53

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2022	2015	2016	2017	2018	2019	2020	2021	2022
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-57.471	-102.883	-24.829	-41.237	-65.636	-40.83	-21.354	-38.16
Return on Equity (%)	-63.223	-120.326	-29.13	-46.618	-89.423	-50.563	-24.008	-43.783
Return on Invested Capital (%)	-63.833	-120.908	-25.338	-58.588	-82.736	-42.004	-32.162	-36.596
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	1.212	0.513	2.054	1.016	0.711	1.764	3.565	2.374
Earnings Per Share	-1.038	-0.945	-0.641	-0.47	-0.592	-0.588	-0.606	-1.297
Cash Per Share	0.492	0.405	2.304	1.078	0.344	0.34	0.47	2.086
Working Capital Per Share	1.208	0.508	2.154	1.013	0.658	1.678	3.426	1.909
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	-1.037	-0.932	-0.641	-0.47	-0.592	-0.588	-0.606	-1.297
EBITDA Per Share	-1.037	-0.932	-0.641	-0.47	-0.592	-0.588	-0.606	-1.297
Free Cash Flow Per Share	-1.036	-0.945	-0.629	-0.432	-0.593	-0.551	-0.561	-0.99

Liquidity Ratios

Year End 31 December 2022	2015	2016	2017	2018	2019	2020	2021	2022
Current Ratio	8.111	5.459	13.095	9.095	2.746	8.719	18.322	7.92
Quick Ratio	7.69	5.115	12.938	8.651	2.259	8.453	17.832	7.605
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	14.23M	16.39M	3.34M	3.51M	10.33M	14.59M	18.33M	18.42M

Key Stats and Ratios

Year End 31 December 2022	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	18.33M	18.37M	18.38M	18.41M	18.42M	18.57M	18.59M	18.6M
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	13.808	N/A	N/A	N/A	6.892	N/A	N/A
Quick Ratio	N/A	13.582	N/A	N/A	N/A	6.618	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	30.76M
Price to Earnings Ratio	-0.99
Price to Sales Ratio	0
Price to Cash Ratio	0.62
Price to Book Ratio	0.54
Dividend Yield	-

Share Statistics

Shares Outstanding	18.42M
Average Volume (1 week)	164.82k
Average Volume (1 Month)	376.06k
52 Week Change	-42.70%
52 Week High	4.59
52 Week Low	1.15

More Ratios Coming Soon!

Enlivex Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions